Finance / GNBT (Generex Biotechnology Corporation)

CEOCast: There was little safe haven for investors last week as the market lost more ground due to a number of disappointing earnings reports and concerning economic releases. All of the major indices traded lower for the week as the Dow lost 446 points for the week, extending its annual loss to 35.9%. The Nasdaq fared no better, losing 131 points and increasing it year-to-date decline to 42.8%. ...

CEOCast: During a historic week as U.S. voters elected the first minority President in the country's history, the markets made their own history of a much more dubious sort, as the Dow experienced the largest two-day decline since the index's inception. Overall, there were few places to hide last week as the market aggressively sold off following the election. The Dow lost 381 points for ...

GNBT, EX. VP and General Counsel buts 25,000 shares at .37,.38. Now owns 225,000. FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company ...

GNBT, EX. VP and General Counsel buts 25,000 shares at .37,.38. Now owns 225,000. FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the ...

GNBT, EX. VP and General Counsel buts 25,000 shares at .37,.38. Now owns 225,000. FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the ...

CEOCast: There was certainly no shortage of news for the financial community to digest last week and extreme volatility remained even as the VIX Index declined below 60 on Friday for the first time since October 21. The Dow gained 946 points, or 11.3%, for the week, trimming its annual loss to 29.7%. The Nasdaq added 169 points for the week and reduced its annual loss to 35.1%. The S&P ...

CEOCast: Wall Street joined stock markets around the world in a huge sell-off last week, sending major market indexes to their lowest levels in more than five years on the belief that a punishing economic recession is at hand. A factor that may have contributed to the downturn was forced selling by hedge funds needing to meet margin calls and redemption requests. The Dow Jones industrial ...

CEOCast: There was blood on Wall Street last week as the major averages plunged further in a historic collapse. The Dow lost an astonishing 1,874 points for the week, or 18.2%, and is now down 36.3% for 2008. The Nasdaq did not do much better with a loss of nearly 298 points for the week to push its year-to-date loss to 37.8%. The S&P dropped 200 points, resulting in a 2008 loss to date of...

CEOcast report today: Drug delivery company Generex Biotechnology Corporation (NASDAQ: GNBT) filed an annual report for its fiscal year ended July 31, 2008. While revenue for fiscal 2008 was only $128,000, investors should remember that the company's flagship oral insulin product, Generex Oral-lyn, is currently not available in the major global markets. However, the fact that Oral-lyn ...

Generex Biotechnology Corp. (Nasdaq:GNBT) announced that The NASDAQ Stock Market (Nasdaq:NDAQ) today cancelled trades in security GNBT at or below $0.36 that were executed in NASDAQ between 11:56:00 and 11:58:00 ET. The cancellations were pursuant to NASDAQ Rule 11890 (b) and cannot be appealed. NASDAQ coordinated this decision with other Unlisted Trading Privileges (UTP) Exchanges....